nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefixime—Diarrhoea—Teniposide—lung cancer	0.00194	0.00196	CcSEcCtD
Cefixime—Erythema multiforme—Gemcitabine—lung cancer	0.00193	0.00194	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Etoposide—lung cancer	0.00192	0.00194	CcSEcCtD
Cefixime—Renal failure—Etoposide—lung cancer	0.00191	0.00192	CcSEcCtD
Cefixime—Blood bilirubin increased—Doxorubicin—lung cancer	0.0019	0.00192	CcSEcCtD
Cefixime—Jaundice—Etoposide—lung cancer	0.00189	0.00191	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Paclitaxel—lung cancer	0.00188	0.0019	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Docetaxel—lung cancer	0.00188	0.0019	CcSEcCtD
Cefixime—Renal failure—Paclitaxel—lung cancer	0.00187	0.00188	CcSEcCtD
Cefixime—Dyspepsia—Topotecan—lung cancer	0.00185	0.00187	CcSEcCtD
Cefixime—Urinary tract infection—Paclitaxel—lung cancer	0.00185	0.00186	CcSEcCtD
Cefixime—Dyspepsia—Erlotinib—lung cancer	0.00183	0.00185	CcSEcCtD
Cefixime—Agranulocytosis—Etoposide—lung cancer	0.00181	0.00182	CcSEcCtD
Cefixime—Vomiting—Teniposide—lung cancer	0.00181	0.00182	CcSEcCtD
Cefixime—Anaphylactic shock—Vinorelbine—lung cancer	0.0018	0.00182	CcSEcCtD
Cefixime—Vaginal inflammation—Doxorubicin—lung cancer	0.0018	0.00181	CcSEcCtD
Cefixime—Flatulence—Irinotecan—lung cancer	0.00179	0.00181	CcSEcCtD
Cefixime—Rash—Teniposide—lung cancer	0.00179	0.00181	CcSEcCtD
Cefixime—Dermatitis—Teniposide—lung cancer	0.00179	0.00181	CcSEcCtD
Cefixime—Headache—Teniposide—lung cancer	0.00178	0.0018	CcSEcCtD
Cefixime—Gastrointestinal pain—Vinblastine—lung cancer	0.00177	0.00179	CcSEcCtD
Cefixime—Thrombocytopenia—Vinorelbine—lung cancer	0.00176	0.00178	CcSEcCtD
Cefixime—Colitis—Doxorubicin—lung cancer	0.00173	0.00174	CcSEcCtD
Cefixime—Gastrointestinal pain—Topotecan—lung cancer	0.00172	0.00174	CcSEcCtD
Cefixime—Candida infection—Doxorubicin—lung cancer	0.00172	0.00173	CcSEcCtD
Cefixime—Pancytopenia—Docetaxel—lung cancer	0.00172	0.00173	CcSEcCtD
Cefixime—Haemoglobin—Paclitaxel—lung cancer	0.00171	0.00173	CcSEcCtD
Cefixime—Abdominal pain—Vinblastine—lung cancer	0.00171	0.00173	CcSEcCtD
Cefixime—Haemorrhage—Paclitaxel—lung cancer	0.00171	0.00172	CcSEcCtD
Cefixime—Gastrointestinal pain—Erlotinib—lung cancer	0.0017	0.00172	CcSEcCtD
Cefixime—Vaginal infection—Doxorubicin—lung cancer	0.0017	0.00171	CcSEcCtD
Cefixime—Neutropenia—Docetaxel—lung cancer	0.00169	0.0017	CcSEcCtD
Cefixime—Nausea—Teniposide—lung cancer	0.00169	0.0017	CcSEcCtD
Cefixime—Aplastic anaemia—Doxorubicin—lung cancer	0.00169	0.0017	CcSEcCtD
Cefixime—Urticaria—Topotecan—lung cancer	0.00167	0.00169	CcSEcCtD
Cefixime—Abdominal pain—Topotecan—lung cancer	0.00167	0.00168	CcSEcCtD
Cefixime—Body temperature increased—Topotecan—lung cancer	0.00167	0.00168	CcSEcCtD
Cefixime—Abdominal pain—Erlotinib—lung cancer	0.00165	0.00166	CcSEcCtD
Cefixime—Body temperature increased—Erlotinib—lung cancer	0.00165	0.00166	CcSEcCtD
Cefixime—Erythema multiforme—Etoposide—lung cancer	0.00164	0.00166	CcSEcCtD
Cefixime—Renal failure acute—Methotrexate—lung cancer	0.00163	0.00165	CcSEcCtD
Cefixime—Leukopenia—Irinotecan—lung cancer	0.00163	0.00164	CcSEcCtD
Cefixime—Flatulence—Cisplatin—lung cancer	0.00163	0.00164	CcSEcCtD
Cefixime—Erythema multiforme—Paclitaxel—lung cancer	0.00161	0.00163	CcSEcCtD
Cefixime—Hypersensitivity—Vinblastine—lung cancer	0.0016	0.00161	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Docetaxel—lung cancer	0.0016	0.00161	CcSEcCtD
Cefixime—Leukopenia—Gemcitabine—lung cancer	0.00159	0.0016	CcSEcCtD
Cefixime—Renal failure—Docetaxel—lung cancer	0.00158	0.0016	CcSEcCtD
Cefixime—Jaundice—Docetaxel—lung cancer	0.00157	0.00158	CcSEcCtD
Cefixime—Anaphylactoid reaction—Methotrexate—lung cancer	0.00156	0.00157	CcSEcCtD
Cefixime—Hypersensitivity—Topotecan—lung cancer	0.00155	0.00157	CcSEcCtD
Cefixime—Agranulocytosis—Docetaxel—lung cancer	0.0015	0.00152	CcSEcCtD
Cefixime—Hepatic function abnormal—Doxorubicin—lung cancer	0.00149	0.00151	CcSEcCtD
Cefixime—Pruritus—Topotecan—lung cancer	0.00149	0.0015	CcSEcCtD
Cefixime—Anaphylactic shock—Irinotecan—lung cancer	0.00149	0.0015	CcSEcCtD
Cefixime—Diarrhoea—Vinblastine—lung cancer	0.00148	0.0015	CcSEcCtD
Cefixime—Leukopenia—Cisplatin—lung cancer	0.00148	0.00149	CcSEcCtD
Cefixime—Pruritus—Erlotinib—lung cancer	0.00147	0.00149	CcSEcCtD
Cefixime—Gastrointestinal pain—Vinorelbine—lung cancer	0.00147	0.00149	CcSEcCtD
Cefixime—Flatulence—Paclitaxel—lung cancer	0.00146	0.00148	CcSEcCtD
Cefixime—Shock—Irinotecan—lung cancer	0.00146	0.00147	CcSEcCtD
Cefixime—Thrombocytopenia—Irinotecan—lung cancer	0.00145	0.00147	CcSEcCtD
Cefixime—Haemoglobin—Docetaxel—lung cancer	0.00145	0.00147	CcSEcCtD
Cefixime—Anaphylactic shock—Gemcitabine—lung cancer	0.00145	0.00146	CcSEcCtD
Cefixime—Hepatitis—Docetaxel—lung cancer	0.00145	0.00146	CcSEcCtD
Cefixime—Haemorrhage—Docetaxel—lung cancer	0.00145	0.00146	CcSEcCtD
Cefixime—Diarrhoea—Topotecan—lung cancer	0.00144	0.00145	CcSEcCtD
Cefixime—Dizziness—Vinblastine—lung cancer	0.00143	0.00145	CcSEcCtD
Cefixime—Convulsion—Cisplatin—lung cancer	0.00143	0.00144	CcSEcCtD
Cefixime—Urticaria—Vinorelbine—lung cancer	0.00143	0.00144	CcSEcCtD
Cefixime—Diarrhoea—Erlotinib—lung cancer	0.00143	0.00144	CcSEcCtD
Cefixime—Abdominal pain—Vinorelbine—lung cancer	0.00142	0.00144	CcSEcCtD
Cefixime—Body temperature increased—Vinorelbine—lung cancer	0.00142	0.00144	CcSEcCtD
Cefixime—Thrombocytopenia—Gemcitabine—lung cancer	0.00142	0.00143	CcSEcCtD
Cefixime—Renal failure acute—Doxorubicin—lung cancer	0.00141	0.00143	CcSEcCtD
Cefixime—Dizziness—Topotecan—lung cancer	0.00139	0.00141	CcSEcCtD
Cefixime—Vomiting—Vinblastine—lung cancer	0.00138	0.00139	CcSEcCtD
Cefixime—Dizziness—Erlotinib—lung cancer	0.00138	0.00139	CcSEcCtD
Cefixime—Renal impairment—Doxorubicin—lung cancer	0.00137	0.00138	CcSEcCtD
Cefixime—Erythema multiforme—Docetaxel—lung cancer	0.00137	0.00138	CcSEcCtD
Cefixime—Dermatitis bullous—Doxorubicin—lung cancer	0.00136	0.00138	CcSEcCtD
Cefixime—Headache—Vinblastine—lung cancer	0.00136	0.00137	CcSEcCtD
Cefixime—Angioedema—Paclitaxel—lung cancer	0.00136	0.00137	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Methotrexate—lung cancer	0.00136	0.00137	CcSEcCtD
Cefixime—Leukopenia—Etoposide—lung cancer	0.00136	0.00137	CcSEcCtD
Cefixime—Anaphylactic shock—Cisplatin—lung cancer	0.00135	0.00136	CcSEcCtD
Cefixime—Anaphylactoid reaction—Doxorubicin—lung cancer	0.00135	0.00136	CcSEcCtD
Cefixime—Vomiting—Topotecan—lung cancer	0.00134	0.00135	CcSEcCtD
Cefixime—Leukopenia—Paclitaxel—lung cancer	0.00133	0.00134	CcSEcCtD
Cefixime—Rash—Topotecan—lung cancer	0.00133	0.00134	CcSEcCtD
Cefixime—Hypersensitivity—Vinorelbine—lung cancer	0.00133	0.00134	CcSEcCtD
Cefixime—Dermatitis—Topotecan—lung cancer	0.00133	0.00134	CcSEcCtD
Cefixime—Vomiting—Erlotinib—lung cancer	0.00132	0.00134	CcSEcCtD
Cefixime—Thrombocytopenia—Cisplatin—lung cancer	0.00132	0.00133	CcSEcCtD
Cefixime—Headache—Topotecan—lung cancer	0.00132	0.00133	CcSEcCtD
Cefixime—Rash—Erlotinib—lung cancer	0.00131	0.00133	CcSEcCtD
Cefixime—Dermatitis—Erlotinib—lung cancer	0.00131	0.00132	CcSEcCtD
Cefixime—Convulsion—Etoposide—lung cancer	0.00131	0.00132	CcSEcCtD
Cefixime—Dyspepsia—Irinotecan—lung cancer	0.00131	0.00132	CcSEcCtD
Cefixime—Headache—Erlotinib—lung cancer	0.00131	0.00132	CcSEcCtD
Cefixime—Eosinophilia—Methotrexate—lung cancer	0.00129	0.0013	CcSEcCtD
Cefixime—Nausea—Vinblastine—lung cancer	0.00129	0.0013	CcSEcCtD
Cefixime—Convulsion—Paclitaxel—lung cancer	0.00129	0.0013	CcSEcCtD
Cefixime—Pruritus—Vinorelbine—lung cancer	0.00127	0.00129	CcSEcCtD
Cefixime—Face oedema—Doxorubicin—lung cancer	0.00126	0.00127	CcSEcCtD
Cefixime—Nausea—Topotecan—lung cancer	0.00125	0.00126	CcSEcCtD
Cefixime—Nausea—Erlotinib—lung cancer	0.00124	0.00125	CcSEcCtD
Cefixime—Pancytopenia—Methotrexate—lung cancer	0.00124	0.00125	CcSEcCtD
Cefixime—Anaphylactic shock—Etoposide—lung cancer	0.00124	0.00125	CcSEcCtD
Cefixime—Diarrhoea—Vinorelbine—lung cancer	0.00123	0.00124	CcSEcCtD
Cefixime—Neutropenia—Methotrexate—lung cancer	0.00122	0.00123	CcSEcCtD
Cefixime—Gastrointestinal pain—Irinotecan—lung cancer	0.00122	0.00123	CcSEcCtD
Cefixime—Anaphylactic shock—Paclitaxel—lung cancer	0.00121	0.00122	CcSEcCtD
Cefixime—Thrombocytopenia—Etoposide—lung cancer	0.00121	0.00122	CcSEcCtD
Cefixime—Shock—Paclitaxel—lung cancer	0.00119	0.0012	CcSEcCtD
Cefixime—Dizziness—Vinorelbine—lung cancer	0.00119	0.0012	CcSEcCtD
Cefixime—Thrombocytopenia—Paclitaxel—lung cancer	0.00119	0.0012	CcSEcCtD
Cefixime—Body temperature increased—Irinotecan—lung cancer	0.00117	0.00119	CcSEcCtD
Cefixime—Abdominal pain—Irinotecan—lung cancer	0.00117	0.00119	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.00117	0.00118	CcSEcCtD
Cefixime—SLC15A2—mammary gland—lung cancer	0.00117	0.134	CbGeAlD
Cefixime—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.00115	0.00116	CcSEcCtD
Cefixime—Vomiting—Vinorelbine—lung cancer	0.00115	0.00116	CcSEcCtD
Cefixime—Body temperature increased—Gemcitabine—lung cancer	0.00114	0.00115	CcSEcCtD
Cefixime—Renal failure—Methotrexate—lung cancer	0.00114	0.00115	CcSEcCtD
Cefixime—Rash—Vinorelbine—lung cancer	0.00114	0.00115	CcSEcCtD
Cefixime—Dermatitis—Vinorelbine—lung cancer	0.00114	0.00114	CcSEcCtD
Cefixime—Headache—Vinorelbine—lung cancer	0.00113	0.00114	CcSEcCtD
Cefixime—Leukopenia—Docetaxel—lung cancer	0.00113	0.00114	CcSEcCtD
Cefixime—Eosinophilia—Doxorubicin—lung cancer	0.00112	0.00113	CcSEcCtD
Cefixime—Hypersensitivity—Irinotecan—lung cancer	0.00109	0.0011	CcSEcCtD
Cefixime—Convulsion—Docetaxel—lung cancer	0.00109	0.0011	CcSEcCtD
Cefixime—Agranulocytosis—Methotrexate—lung cancer	0.00108	0.00109	CcSEcCtD
Cefixime—Pancytopenia—Doxorubicin—lung cancer	0.00107	0.00108	CcSEcCtD
Cefixime—Nausea—Vinorelbine—lung cancer	0.00107	0.00108	CcSEcCtD
Cefixime—Dyspepsia—Paclitaxel—lung cancer	0.00107	0.00108	CcSEcCtD
Cefixime—Body temperature increased—Cisplatin—lung cancer	0.00107	0.00108	CcSEcCtD
Cefixime—Neutropenia—Doxorubicin—lung cancer	0.00105	0.00106	CcSEcCtD
Cefixime—Haemoglobin—Methotrexate—lung cancer	0.00105	0.00106	CcSEcCtD
Cefixime—Hepatitis—Methotrexate—lung cancer	0.00104	0.00105	CcSEcCtD
Cefixime—Haemorrhage—Methotrexate—lung cancer	0.00104	0.00105	CcSEcCtD
Cefixime—SLC15A1—epithelium—lung cancer	0.00104	0.119	CbGeAlD
Cefixime—Anaphylactic shock—Docetaxel—lung cancer	0.00103	0.00104	CcSEcCtD
Cefixime—Pruritus—Gemcitabine—lung cancer	0.00102	0.00103	CcSEcCtD
Cefixime—Diarrhoea—Irinotecan—lung cancer	0.00102	0.00103	CcSEcCtD
Cefixime—SLC22A5—mammary gland—lung cancer	0.00101	0.116	CbGeAlD
Cefixime—Gastrointestinal pain—Etoposide—lung cancer	0.00101	0.00102	CcSEcCtD
Cefixime—Shock—Docetaxel—lung cancer	0.00101	0.00102	CcSEcCtD
Cefixime—Thrombocytopenia—Docetaxel—lung cancer	0.00101	0.00101	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000997	0.00101	CcSEcCtD
Cefixime—Hypersensitivity—Cisplatin—lung cancer	0.000994	0.001	CcSEcCtD
Cefixime—Gastrointestinal pain—Paclitaxel—lung cancer	0.000991	0.001	CcSEcCtD
Cefixime—Diarrhoea—Gemcitabine—lung cancer	0.00099	0.000999	CcSEcCtD
Cefixime—Renal failure—Doxorubicin—lung cancer	0.000988	0.000997	CcSEcCtD
Cefixime—Erythema multiforme—Methotrexate—lung cancer	0.000985	0.000994	CcSEcCtD
Cefixime—Dizziness—Irinotecan—lung cancer	0.000983	0.000991	CcSEcCtD
Cefixime—Urticaria—Etoposide—lung cancer	0.000982	0.000991	CcSEcCtD
Cefixime—Jaundice—Doxorubicin—lung cancer	0.00098	0.000988	CcSEcCtD
Cefixime—Abdominal pain—Etoposide—lung cancer	0.000977	0.000986	CcSEcCtD
Cefixime—Body temperature increased—Etoposide—lung cancer	0.000977	0.000986	CcSEcCtD
Cefixime—Urinary tract infection—Doxorubicin—lung cancer	0.000977	0.000986	CcSEcCtD
Cefixime—Urticaria—Paclitaxel—lung cancer	0.000963	0.000971	CcSEcCtD
Cefixime—Abdominal pain—Paclitaxel—lung cancer	0.000958	0.000966	CcSEcCtD
Cefixime—Body temperature increased—Paclitaxel—lung cancer	0.000958	0.000966	CcSEcCtD
Cefixime—Vomiting—Irinotecan—lung cancer	0.000945	0.000953	CcSEcCtD
Cefixime—Agranulocytosis—Doxorubicin—lung cancer	0.000938	0.000946	CcSEcCtD
Cefixime—Rash—Irinotecan—lung cancer	0.000937	0.000945	CcSEcCtD
Cefixime—Dermatitis—Irinotecan—lung cancer	0.000936	0.000944	CcSEcCtD
Cefixime—Headache—Irinotecan—lung cancer	0.000931	0.000939	CcSEcCtD
Cefixime—Diarrhoea—Cisplatin—lung cancer	0.000923	0.000931	CcSEcCtD
Cefixime—Vomiting—Gemcitabine—lung cancer	0.00092	0.000928	CcSEcCtD
Cefixime—Rash—Gemcitabine—lung cancer	0.000913	0.000921	CcSEcCtD
Cefixime—Dermatitis—Gemcitabine—lung cancer	0.000912	0.00092	CcSEcCtD
Cefixime—Hypersensitivity—Etoposide—lung cancer	0.000911	0.000919	CcSEcCtD
Cefixime—Haemoglobin—Doxorubicin—lung cancer	0.000907	0.000915	CcSEcCtD
Cefixime—Headache—Gemcitabine—lung cancer	0.000907	0.000915	CcSEcCtD
Cefixime—Dyspepsia—Docetaxel—lung cancer	0.000904	0.000912	CcSEcCtD
Cefixime—Haemorrhage—Doxorubicin—lung cancer	0.000902	0.00091	CcSEcCtD
Cefixime—Hepatitis—Doxorubicin—lung cancer	0.000902	0.00091	CcSEcCtD
Cefixime—Hypersensitivity—Paclitaxel—lung cancer	0.000893	0.000901	CcSEcCtD
Cefixime—Nausea—Irinotecan—lung cancer	0.000883	0.00089	CcSEcCtD
Cefixime—Pruritus—Etoposide—lung cancer	0.000874	0.000882	CcSEcCtD
Cefixime—Nausea—Gemcitabine—lung cancer	0.00086	0.000867	CcSEcCtD
Cefixime—Vomiting—Cisplatin—lung cancer	0.000858	0.000865	CcSEcCtD
Cefixime—Pruritus—Paclitaxel—lung cancer	0.000857	0.000865	CcSEcCtD
Cefixime—Erythema multiforme—Doxorubicin—lung cancer	0.000853	0.000861	CcSEcCtD
Cefixime—Rash—Cisplatin—lung cancer	0.000851	0.000858	CcSEcCtD
Cefixime—Dermatitis—Cisplatin—lung cancer	0.00085	0.000857	CcSEcCtD
Cefixime—Diarrhoea—Etoposide—lung cancer	0.000846	0.000853	CcSEcCtD
Cefixime—Gastrointestinal pain—Docetaxel—lung cancer	0.00084	0.000847	CcSEcCtD
Cefixime—Diarrhoea—Paclitaxel—lung cancer	0.000829	0.000836	CcSEcCtD
Cefixime—Dizziness—Etoposide—lung cancer	0.000817	0.000825	CcSEcCtD
Cefixime—Abdominal pain—Docetaxel—lung cancer	0.000812	0.000819	CcSEcCtD
Cefixime—Body temperature increased—Docetaxel—lung cancer	0.000812	0.000819	CcSEcCtD
Cefixime—Leukopenia—Methotrexate—lung cancer	0.000812	0.000819	CcSEcCtD
Cefixime—Dizziness—Paclitaxel—lung cancer	0.000801	0.000808	CcSEcCtD
Cefixime—Nausea—Cisplatin—lung cancer	0.000801	0.000808	CcSEcCtD
Cefixime—Convulsion—Methotrexate—lung cancer	0.000786	0.000793	CcSEcCtD
Cefixime—Vomiting—Etoposide—lung cancer	0.000786	0.000793	CcSEcCtD
Cefixime—Rash—Etoposide—lung cancer	0.000779	0.000786	CcSEcCtD
Cefixime—Dermatitis—Etoposide—lung cancer	0.000779	0.000785	CcSEcCtD
Cefixime—SLC15A2—respiratory system—lung cancer	0.000777	0.0892	CbGeAlD
Cefixime—Headache—Etoposide—lung cancer	0.000774	0.000781	CcSEcCtD
Cefixime—Flatulence—Doxorubicin—lung cancer	0.000774	0.000781	CcSEcCtD
Cefixime—Vomiting—Paclitaxel—lung cancer	0.000771	0.000777	CcSEcCtD
Cefixime—Rash—Paclitaxel—lung cancer	0.000764	0.000771	CcSEcCtD
Cefixime—Dermatitis—Paclitaxel—lung cancer	0.000763	0.00077	CcSEcCtD
Cefixime—Headache—Paclitaxel—lung cancer	0.000759	0.000766	CcSEcCtD
Cefixime—Hypersensitivity—Docetaxel—lung cancer	0.000757	0.000763	CcSEcCtD
Cefixime—Anaphylactic shock—Methotrexate—lung cancer	0.00074	0.000747	CcSEcCtD
Cefixime—Nausea—Etoposide—lung cancer	0.000734	0.000741	CcSEcCtD
Cefixime—Pruritus—Docetaxel—lung cancer	0.000727	0.000733	CcSEcCtD
Cefixime—Thrombocytopenia—Methotrexate—lung cancer	0.000725	0.000731	CcSEcCtD
Cefixime—Nausea—Paclitaxel—lung cancer	0.00072	0.000726	CcSEcCtD
Cefixime—Leukopenia—Doxorubicin—lung cancer	0.000703	0.000709	CcSEcCtD
Cefixime—Diarrhoea—Docetaxel—lung cancer	0.000703	0.000709	CcSEcCtD
Cefixime—Convulsion—Doxorubicin—lung cancer	0.000681	0.000687	CcSEcCtD
Cefixime—Dizziness—Docetaxel—lung cancer	0.000679	0.000685	CcSEcCtD
Cefixime—SLC22A5—respiratory system—lung cancer	0.000676	0.0776	CbGeAlD
Cefixime—Vomiting—Docetaxel—lung cancer	0.000653	0.000659	CcSEcCtD
Cefixime—Dyspepsia—Methotrexate—lung cancer	0.000652	0.000657	CcSEcCtD
Cefixime—Rash—Docetaxel—lung cancer	0.000648	0.000653	CcSEcCtD
Cefixime—Dermatitis—Docetaxel—lung cancer	0.000647	0.000653	CcSEcCtD
Cefixime—Headache—Docetaxel—lung cancer	0.000644	0.000649	CcSEcCtD
Cefixime—Anaphylactic shock—Doxorubicin—lung cancer	0.000641	0.000647	CcSEcCtD
Cefixime—SLC15A2—bronchus—lung cancer	0.000639	0.0734	CbGeAlD
Cefixime—Shock—Doxorubicin—lung cancer	0.000631	0.000636	CcSEcCtD
Cefixime—Thrombocytopenia—Doxorubicin—lung cancer	0.000628	0.000633	CcSEcCtD
Cefixime—Nausea—Docetaxel—lung cancer	0.00061	0.000616	CcSEcCtD
Cefixime—Gastrointestinal pain—Methotrexate—lung cancer	0.000605	0.000611	CcSEcCtD
Cefixime—Urticaria—Methotrexate—lung cancer	0.000588	0.000593	CcSEcCtD
Cefixime—Abdominal pain—Methotrexate—lung cancer	0.000585	0.00059	CcSEcCtD
Cefixime—Body temperature increased—Methotrexate—lung cancer	0.000585	0.00059	CcSEcCtD
Cefixime—SLC15A2—trachea—lung cancer	0.000574	0.0659	CbGeAlD
Cefixime—Dyspepsia—Doxorubicin—lung cancer	0.000564	0.000569	CcSEcCtD
Cefixime—SLC22A5—bronchus—lung cancer	0.000556	0.0639	CbGeAlD
Cefixime—Hypersensitivity—Methotrexate—lung cancer	0.000545	0.00055	CcSEcCtD
Cefixime—Gastrointestinal pain—Doxorubicin—lung cancer	0.000524	0.000529	CcSEcCtD
Cefixime—Pruritus—Methotrexate—lung cancer	0.000524	0.000528	CcSEcCtD
Cefixime—Urticaria—Doxorubicin—lung cancer	0.000509	0.000514	CcSEcCtD
Cefixime—Body temperature increased—Doxorubicin—lung cancer	0.000507	0.000511	CcSEcCtD
Cefixime—Abdominal pain—Doxorubicin—lung cancer	0.000507	0.000511	CcSEcCtD
Cefixime—Diarrhoea—Methotrexate—lung cancer	0.000507	0.000511	CcSEcCtD
Cefixime—SLC22A5—trachea—lung cancer	0.000499	0.0573	CbGeAlD
Cefixime—Dizziness—Methotrexate—lung cancer	0.00049	0.000494	CcSEcCtD
Cefixime—Hypersensitivity—Doxorubicin—lung cancer	0.000472	0.000476	CcSEcCtD
Cefixime—Vomiting—Methotrexate—lung cancer	0.000471	0.000475	CcSEcCtD
Cefixime—SLC22A5—cardiac atrium—lung cancer	0.000469	0.0539	CbGeAlD
Cefixime—Rash—Methotrexate—lung cancer	0.000467	0.000471	CcSEcCtD
Cefixime—Dermatitis—Methotrexate—lung cancer	0.000466	0.00047	CcSEcCtD
Cefixime—Headache—Methotrexate—lung cancer	0.000464	0.000468	CcSEcCtD
Cefixime—Pruritus—Doxorubicin—lung cancer	0.000454	0.000458	CcSEcCtD
Cefixime—Nausea—Methotrexate—lung cancer	0.00044	0.000444	CcSEcCtD
Cefixime—Diarrhoea—Doxorubicin—lung cancer	0.000439	0.000442	CcSEcCtD
Cefixime—Dizziness—Doxorubicin—lung cancer	0.000424	0.000428	CcSEcCtD
Cefixime—SLC15A2—lung—lung cancer	0.000412	0.0474	CbGeAlD
Cefixime—Vomiting—Doxorubicin—lung cancer	0.000408	0.000411	CcSEcCtD
Cefixime—Rash—Doxorubicin—lung cancer	0.000404	0.000408	CcSEcCtD
Cefixime—Dermatitis—Doxorubicin—lung cancer	0.000404	0.000407	CcSEcCtD
Cefixime—Headache—Doxorubicin—lung cancer	0.000402	0.000405	CcSEcCtD
Cefixime—Nausea—Doxorubicin—lung cancer	0.000381	0.000384	CcSEcCtD
Cefixime—SLC22A5—lung—lung cancer	0.000359	0.0412	CbGeAlD
Cefixime—SLC15A2—lymph node—lung cancer	0.000282	0.0324	CbGeAlD
Cefixime—SLC22A5—lymph node—lung cancer	0.000245	0.0282	CbGeAlD
